Mapping cerebral atrophic trajectory from amnestic mild cognitive impairment to Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Cerebral Cortex

• Publication date

  2022-04-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cercor/bhac137PMID 35368064PMCID PMC9930625
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease

  2021cited by this paper
• Segmented Linear Mixed Model Analysis Reveals Association of the APOE ɛ4 Allele with Faster Rate of Alzheimer’s Disease Dementia Progression

  2021cited by this paper
• The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals

  2021cited by this paper
• On the Power of the F-test for Hypotheses in a Linear Model

  2021cited by this paper
• An inflammatory cytokine signature predicts COVID-19 severity and survival

  2020cited by this paper
• Automated anatomical labelling atlas 3

  2020cited by this paper
• Nonlinear interaction between APOE ε4 allele load and age in the hippocampal surface of cognitively intact individuals

  2020cited by this paper
• Prediction of clinical and biomarker conformed Alzheimer’s disease and mild cognitive impairment from multi-feature brain structural MRI using age-correction from a large independent lifespan sample

  2020cited by this paper
• Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study

  2020cited by this paper
• Prediction of conversion to Alzheimer’s disease using deep survival analysis of MRI images

  2020cited by this paper
• Evidence of parietal hyperactivation in individuals with mild cognitive impairment who progressed to dementia: A longitudinal fMRI study

  2019cited by this paper
• Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease

  2019cited by this paper
• Risk factors for Alzheimer's disease.

  2019cited by this paper
• Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer’s Disease

  2019cited by this paper
• Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study

  2019cited by this paper
• Multi-modal imaging with specialized sequences improves accuracy of the automated subcortical grey matter segmentation.

  2019cited by this paper
• Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease.

  2019cited by this paper
• The striatum, the hippocampus, and short-term memory binding: Volumetric analysis of the subcortical grey matter's role in mild cognitive impairment

  2019cited by this paper
• When Does Alzheimer′s Disease Really Start? The Role of Biomarkers

  2019cited by this paper
• Predicting time to dementia using a quantitative template of disease progression

  2018influential reference
• Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease

  2018cited by this paper
• Conversion and time‐to‐conversion predictions of mild cognitive impairment using low‐rank affinity pursuit denoising and matrix completion

  2018cited by this paper
• Patterns of progressive atrophy vary with age in Alzheimer's disease patients

  2018cited by this paper
• Effects of APOE‐ε4 allele load on brain morphology in a cohort of middle‐aged healthy individuals with enriched genetic risk for Alzheimer's disease

  2018cited by this paper
• Brain properties predict proximity to symptom onset in sporadic Alzheimer’s disease

  2018cited by this paper
• Gray Matter Atrophy Is Associated With Cognitive Impairment in Patients With Presbycusis: A Comprehensive Morphometric Study

  2018cited by this paper
• Longitudinal brain structural changes in preclinical Alzheimer's disease

  2017cited by this paper
• Single subject prediction of brain disorders in neuroimaging: Promises and pitfalls

  2017cited by this paper
• Adverse Effects of the Apolipoprotein E ε4 Allele on Episodic Memory, Task Switching and Gray Matter Volume in Healthy Young Adults

  2017cited by this paper
• Automatic segmentation of the striatum and globus pallidus using MIST: Multimodal Image Segmentation Tool

  2016cited by this paper
• Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease

  2016cited by this paper
• DTI Analysis of Presbycusis Using Voxel-Based Analysis

  2016cited by this paper
• Brain atrophy in Alzheimer's Disease and aging.

  2016cited by this paper
• Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

  2016cited by this paper
• Biomarkers for the Early Detection and Progression of Alzheimer’s Disease

  2016cited by this paper
• Instantiated mixed effects modeling of Alzheimer's disease markers

  2016cited by this paper
• Decreased auditory GABA + concentrations in presbycusis demonstrated by edited magnetic resonance spectroscopy

  2015cited by this paper
• White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.

  2015cited by this paper
• Large intracranial volume accelerates conversion to dementia in males and APOE4 non-carriers with mild cognitive impairment

  2015cited by this paper
• Cognition, Brain Atrophy, and Cerebrospinal Fluid Biomarkers Changes from Preclinical to Dementia Stage of Alzheimer's Disease and the Influence of Apolipoprotein E

  2015cited by this paper
• Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease

  2015cited by this paper
• The age factor in Alzheimer’s disease

  2015cited by this paper
• Age-related hearing impairment—a risk factor and frailty marker for dementia and AD

  2015cited by this paper
• Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease

  2014influential reference
• Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: Detecting, quantifying, and predicting

  2014cited by this paper
• Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.

  2014cited by this paper
• Alzheimer's

  2014influential reference
• APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years.

  2014cited by this paper
• Modular reorganization of brain resting state networks and its independent validation in Alzheimer's disease patients

  2013cited by this paper
• Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR-SOB Scores From ADNI

  2013cited by this paper
• Biomarker modeling of Alzheimer's disease.

  2013cited by this paper
• Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models

  2013cited by this paper
• Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease

  2013cited by this paper
• Longitudinal changes of cortical thickness in early- versus late-onset Alzheimer's disease.

  2013cited by this paper
• Age and rate of cognitive decline in Alzheimer disease: implications for clinical trials.

  2012cited by this paper
• Rates of Decline in Alzheimer Disease Decrease with Age

  2012cited by this paper
• Structural MRI changes detectable up to ten years before clinical Alzheimer's disease.

  2012cited by this paper
• Gene dose of apolipoprotein E and age-related hearing loss.

  2012cited by this paper
• Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease.

  2011cited by this paper
• Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification.

  2011cited by this paper
• Volume reduction in subcortical regions according to severity of Alzheimer’s disease

  2011cited by this paper
• Longitudinal change of biomarkers in cognitive decline.

  2011cited by this paper
• Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort.

  2010cited by this paper
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

  2010cited by this paper
• Alzheimer's Disease Neuroimaging Initiative (ADNI)

  2010cited by this paper
• Progression of Atrophy in Alzheimer’s Disease and Related Disorders

  2010cited by this paper
• Automated MRI measures predict progression to Alzheimer's disease.

  2010cited by this paper
• Mini Mental State

  2010cited by this paper
• Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort

  2009cited by this paper
• Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.

  2009cited by this paper
• P3‐080: Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short‐term conversion to AD: Results from ADNI

  2009cited by this paper
• Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.

  2008influential reference
• MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

  2008cited by this paper
• Atrophy rates accelerate in amnestic mild cognitive impairment

  2008cited by this paper
• A fast diffeomorphic image registration algorithm

  2007cited by this paper
• Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.

  2006cited by this paper
• Reduced hippocampal volume in non-demented carriers fo the apolipoprotein E ε4: Relation to chronological age and recognition memory

  2006cited by this paper
• Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.

  2006cited by this paper
• Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease

  2004cited by this paper
• Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.

  2004cited by this paper
• Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

  2002cited by this paper
• Current concepts in mild cognitive impairment.

  2001cited by this paper
• Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.

  2001cited by this paper
• [Risk factors for Alzheimer's disease].

  2000cited by this paper
• The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease

  1999cited by this paper
• Automatic segmentation

  1986cited by this paper
• Cross-Validation Of Covariance Structures.

  1983cited by this paper

• Changes in Naturalistic Viewing in Healthy Aging and Amnestic Mild Cognitive Impairment

  2025cites this paper
• Effect of acupuncture on episodic memory for amnestic mild cognitive impairment based on hippocampal subregion: study protocol of a randomized, controlled trial

  2025cites this paper
• Selective Plasticity of Hippocampal Sub‐Regions in the Amnestic Mild Cognitive Impairment After Acupuncture

  2025cites this paper
• Revealing heterogeneity in mild cognitive impairment based on individualized structural covariance network

  2025cites this paper
• Brain functional alterations in early stage of coal workers’ pneumoconiosis with alcoholism: insights from a resting-state fMRI investigation

  2025cites this paper
• Subtype-Specific Brain Atrophy and White Matter Alterations in Mild Cognitive Impairment

  2025cites this paper
• Trajectory of olfactory cortex degeneration from normal cognition to Alzheimer's disease: Insights from multimodal neuroimaging.

  2025cites this paper
• Patterns of longitudinal subcortical atrophy over one year in amnestic mild cognitive impairment and its impact on cognitive performance: a preliminary study

  2024cites this paper
• p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial

  2024cites this paper
• The characteristics of brain atrophy prior to the onset of Alzheimer’s disease: a longitudinal study

  2024cites this paper
• Exploring the Relationship between Behavioral and Neurological Impairments Due to Mild Cognitive Impairment: Correlation Study between Virtual Kiosk Test and EEG-SSVEP

  2024cites this paper
• Heterogeneity of cerebral atrophic rate in mild cognitive impairment and its interactive association with proteins related to microglia activity on longitudinal cognitive changes.

  2024cites this paper
• Apolipoprotein E ε4 accelerates the longitudinal cerebral atrophy in open access series of imaging studies-3 elders without dementia at enrollment

  2023cites this paper
• Differential decay of gist and detail memory in older adults with amnestic mild cognitive impairment.

  2023cites this paper
• Korsakoff’s Syndrome and Alzheimer’s Disease—Commonalities and Specificities of Volumetric Brain Alterations within Papez Circuit

  2023cites this paper
• Association between gray matter atrophy, cerebral hypoperfusion, and cognitive impairment in Alzheimer’s disease

  2023cites this paper
• Diencephalic or hippocampal amnesia: different etiologies, common mechanisms.

  2022cites this paper